Henry Schein, Inc. (HSIC) Stock Analysis
Last updated Sep 8, 2026
Health Check
Last analyzed Sep 7, 2026
- Financial Health 65
- Profitability 50
- Business Quality 60
- Balance Sheet 40
- Cash Flow 80
Why this rating?
Health 60/100 — Good Quality
Worth tracking, but timing is mixed — not a clear setup yet.
Company overview
Henry Schein, Inc. (HSIC) is a Medical Distribution company in the Healthcare sector. Compound Radar rates Henry Schein, Inc. 60/100 (Good Quality) due to solid business quality, steady revenue growth, and elevated leverage.
Investment profile
- Quality Moderate
- Growth Moderate
- Balance Sheet Stretched
- Valuation Attractive
Financial highlights
Valuation
- P/E 25.91
- Forward P/E 14.81
- PEG 1.79
- EV/Revenue 1.12
Profitability
- Revenue Growth 6.7%
- Gross Margin 31.3%
- Operating Margin 5.8%
- Net Margin 3.0%
- ROE 8.9%
Financial strength
- Cash $157.00M
- Debt $3.81B
- Net Cash $-3.66B
- Free Cash Flow $521.00M
- Current Ratio 1.32
Similar companies
Peers in Medical Distribution, ranked by Financial Health.
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- McKesson Corporation Medical Distribution MCK$889.12 63 Health 63 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Cencora, Inc. Medical Distribution COR$324.69 58 Health 58 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Cardinal Health, Inc. Medical Distribution CAH$240.49 55 Health 55 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
FAQ
How Compound Radar scores and tracks Henry Schein, Inc. (HSIC).